The National Health Service (Pharmaceutical Services) Amendment Regulations 2011

Transitional arrangements

4.—(1) This regulation has effect only in relation to the provision of pharmaceutical services at any time before the end of the transitional period by a pharmacist whose name was, immediately before these Regulations come into force, already on a pharmaceutical list maintained by a Primary Care Trust under the principal Regulations.

(2) Subject to paragraph (3), during the transitional period the pharmacist is not bound by—

(a) any particular amendment to paragraph 26(2) of Schedule 1 to the principal Regulations (clinical governance) made by regulation 3(2)(a), (4)(b), (5)(a) or (6), if they choose instead to comply, and do comply, with the provision modified or substituted by that particular amendment as it had effect prior to that particular amendment; or

(b) the amendments to paragraph 26(2) of Schedule 1 to the principal Regulations made by regulation 3(4)(a), (4)(c), (5)(b) to (d) and (7).

(3) Nothing in this regulation affects the duty of a pharmacist—

(a) before the end of the transitional period, to comply with paragraph 26(2) of Schedule 1 to the principal Regulations, as it otherwise has effect; and

(b) at and after the end of the transitional period, to comply with paragraph 26(2) of Schedule 1 to the principal Regulations as amended by these Regulations.

(4) In this regulation, “transitional period” means the period that begins on the day that these Regulations come into force and ends at the end of 31st March 2012.